Xiao Dong Yang
Founder at Apexigen America, Inc.
Profile
Xiao Dong Yang is the founder of three companies.
Abgenix, Inc. was founded in 1995, Apexigen America, Inc. was founded in 2010, and Apexigen, Inc. was also founded in 2010.
At Abgenix, Inc., he held the title of Scientist from 1995 to 2013.
At Apexigen America, Inc., he currently holds the titles of President, Chief Executive Officer & Director.
At Apexigen, Inc., he held the title of Chief Executive Officer & Director in 2023.
Dr. Yang's former jobs include Senior Director-Cancer Pharmacology at Amgen, Inc. in 2006, Member at Novartis Corp., VP-Research & Preclinical Development at Intradigm Corp., and Vice President-Preclinical Development at Silence Therapeutics Plc from 2009 to 2010.
Dr. Yang received a doctorate from the University of Bern and an undergraduate degree from Beijing University of Traditional Chinese Medicine.
Xiao Dong Yang active positions
| Companies | Position | Start |
|---|---|---|
Apexigen America, Inc.
 Apexigen America, Inc. Pharmaceuticals: MajorHealth Technology Apexigen America, Inc. is a clinical-stage biopharmaceutical company, which focuses on the discovery and development of innovative antibody-based therapeutics for the treatment of cancer with a focus on immuno-oncology. Its product portfolio includes humanized antibodies, targeting diseases such as cancer, inflammatory diseases and ophthalmic disease. The company was founded by Xiao Dong Yang in July 2010 and is headquartered in San Carlos, CA. | Founder | 01/07/2010 |
Former positions of Xiao Dong Yang
| Companies | Position | End |
|---|---|---|
| APEXIGEN, INC. | Founder | 23/08/2023 |
| SILENCE THERAPEUTICS PLC | Corporate Officer/Principal | 01/05/2010 |
| AMGEN INC. | Corporate Officer/Principal | 01/08/2006 |
Abgenix, Inc.
 Abgenix, Inc. BiotechnologyHealth Technology Abgenix, Inc. developed therapeutic products. It focused on the discovery, development and manufacturing of therapeutic antibodies. The firm's antibody development platform included manufacturing fully human antibody product candidates to a variety of disease targets. The company was founded by R. Scott Greer in 1996 and was headquartered in Fremont, CA. | Founder | - |
Novartis Corp.
 Novartis Corp. Pharmaceuticals: MajorHealth Technology Novartis Corp. manufactures pharmaceuticals, vaccines, consumer health, generics, eye care and animal health products. It manufactures drugs for oncology, hypertension, diabetes, cancer and cardiovascular diseases. The company was founded on November 15, 1996 and is headquartered in New York, NY. | Corporate Officer/Principal | - |
Training of Xiao Dong Yang
| University of Bern | Doctorate Degree |
| Beijing University of Traditional Chinese Medicine | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 3 |
|---|---|
| AMGEN INC. | Health Technology |
| SILENCE THERAPEUTICS PLC | Commercial Services |
| APEXIGEN, INC. | Health Technology |
| Private companies | 4 |
|---|---|
Abgenix, Inc.
Abgenix, Inc. BiotechnologyHealth Technology Abgenix, Inc. developed therapeutic products. It focused on the discovery, development and manufacturing of therapeutic antibodies. The firm's antibody development platform included manufacturing fully human antibody product candidates to a variety of disease targets. The company was founded by R. Scott Greer in 1996 and was headquartered in Fremont, CA. | Health Technology |
Novartis Corp.
Novartis Corp. Pharmaceuticals: MajorHealth Technology Novartis Corp. manufactures pharmaceuticals, vaccines, consumer health, generics, eye care and animal health products. It manufactures drugs for oncology, hypertension, diabetes, cancer and cardiovascular diseases. The company was founded on November 15, 1996 and is headquartered in New York, NY. | Health Technology |
Intradigm Corp.
 Intradigm Corp. Pharmaceuticals: MajorHealth Technology Intradigm Corp. develops drugs and therapies. Its RNAi therapeutic platform comprised of proprietary delivery technologies, potent siRNA sequences and innovative siRNA structural features. The company was founded by Puthupparampil Scaria, Martin C. Woodle, Wei-Wu He and Patrick Y. Lu in 2000 and is headquartered in Palo Alto, CA. | Health Technology |
Apexigen America, Inc.
Apexigen America, Inc. Pharmaceuticals: MajorHealth Technology Apexigen America, Inc. is a clinical-stage biopharmaceutical company, which focuses on the discovery and development of innovative antibody-based therapeutics for the treatment of cancer with a focus on immuno-oncology. Its product portfolio includes humanized antibodies, targeting diseases such as cancer, inflammatory diseases and ophthalmic disease. The company was founded by Xiao Dong Yang in July 2010 and is headquartered in San Carlos, CA. | Health Technology |
- Stock Market
- Insiders
- Xiao Dong Yang
